NSPR InspireMD, Inc.

-

InspireMD Beat Consensus Estimates

Friday, August 14, 2026 · 12:00 AM ET

InspireMD (NSPR) reported a loss of $0.17 per share on revenue of $1.77 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.20 per share. The company beat consensus estimates by 15.00% while revenue fell 0.39% compared to the same quarter a year ago.

InspireMD Inc together with its subsidiaries, is a medical device company focusing on the development and commercialization of its proprietary stent platform technology, MGuard™.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.17)
Earnings Whisper®
Consensus Estimate
($0.20)
Earnings Surprise
Earnings Growth34.6 %
Reported Revenue
$1.77M
Revenue Estimate
Revenue Surprise
Revenue Growth-0.4 %